Drug Profile
NXL 101
Alternative Names: AVE-4221; NXL-101Latest Information Update: 02 Dec 2008
Price :
$50
*
At a glance
- Originator Novexel
- Class Antibacterials; Carboxylic acids; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Methicillin-resistant Staphylococcus aureus infections; Nosocomial infections
Most Recent Events
- 28 Jun 2008 Discontinued - Phase-I for Meticillin-resistant Staphylococcus aureus infections in France (IV)
- 28 Jun 2008 Discontinued - Phase-I for Meticillin-resistant Staphylococcus aureus infections in France (PO)
- 28 Jun 2008 Discontinued - Phase-I for Nosocomial infections in France (IV)